Amarin Corporation Statistics
Total Valuation
AMRN has a market cap or net worth of $247.61 million. The enterprise value is -$68.16 million.
| Market Cap | 247.61M |
| Enterprise Value | -68.16M |
Important Dates
The last earnings date was Wednesday, October 28, 2026, before market open.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AMRN has 21.07 million shares outstanding. The number of shares has increased by 1.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 21.07M |
| Shares Change (YoY) | +1.30% |
| Shares Change (QoQ) | +2.74% |
| Owned by Insiders (%) | 1.94% |
| Owned by Institutions (%) | 15.03% |
| Float | 19.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| Forward PS | 1.43 |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | 6.60 |
| P/OCF Ratio | 6.60 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.50, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.50 |
| Quick Ratio | 2.49 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.20 |
| Interest Coverage | -3,514.57 |
Financial Efficiency
Return on equity (ROE) is -4.24% and return on invested capital (ROIC) is -18.58%.
| Return on Equity (ROE) | -4.24% |
| Return on Assets (ROA) | -2.38% |
| Return on Invested Capital (ROIC) | -18.58% |
| Return on Capital Employed (ROCE) | -5.36% |
| Weighted Average Cost of Capital (WACC) | 8.32% |
| Revenue Per Employee | $2.20M |
| Profits Per Employee | -$239,263 |
| Employee Count | 80 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 0.61 |
Taxes
In the past 12 months, AMRN has paid $2.01 million in taxes.
| Income Tax | 2.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.21% in the last 52 weeks. The beta is 0.79, so AMRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -25.21% |
| 50-Day Moving Average | 12.66 |
| 200-Day Moving Average | 14.19 |
| Relative Strength Index (RSI) | 42.77 |
| Average Volume (20 Days) | 79,689 |
Short Selling Information
The latest short interest is 532,662, so 1.28% of the outstanding shares have been sold short.
| Short Interest | 532,662 |
| Short Previous Month | 528,373 |
| Short % of Shares Out | 1.28% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.68 |
Income Statement
In the last 12 months, AMRN had revenue of $176.11 million and -$19.14 million in losses. Loss per share was -$0.91.
| Revenue | 176.11M |
| Gross Profit | 72.11M |
| Operating Income | -24.60M |
| Pretax Income | -17.13M |
| Net Income | -19.14M |
| EBITDA | -21.99M |
| EBIT | -24.60M |
| Loss Per Share | -$0.91 |
Balance Sheet
The company has $323.38 million in cash and $7.61 million in debt, with a net cash position of $315.77 million or $14.98 per share.
| Cash & Cash Equivalents | 323.38M |
| Total Debt | 7.61M |
| Net Cash | 315.77M |
| Net Cash Per Share | $14.98 |
| Equity (Book Value) | 444.41M |
| Book Value Per Share | 21.08 |
| Working Capital | 437.74M |
Cash Flow
| Operating Cash Flow | 37.49M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.62M |
| Net Borrowing | n/a |
| Free Cash Flow | 37.49M |
| FCF Per Share | $1.78 |
Margins
Gross margin is 40.94%, with operating and profit margins of -13.97% and -10.87%.
| Gross Margin | 40.94% |
| Operating Margin | -13.97% |
| Pretax Margin | -9.73% |
| Profit Margin | -10.87% |
| EBITDA Margin | -12.48% |
| EBIT Margin | -13.97% |
| FCF Margin | 21.29% |
Dividends & Yields
AMRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.30% |
| Shareholder Yield | -1.30% |
| Earnings Yield | -7.77% |
| FCF Yield | 15.14% |
Analyst Forecast
The average price target for AMRN is $12.50, which is 6.38% higher than the current price. The consensus rating is "Strong Sell".
| Price Target | $12.50 |
| Price Target Difference | 6.38% |
| Analyst Consensus | Strong Sell |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -4.67% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on April 11, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 11, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
AMRN has an Altman Z-Score of -1.83 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.83 |
| Piotroski F-Score | 3 |